RHYTHM PHARMACEUTICALS, INC. (RYTM) Total liabilities 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) total liabilities at each fiscal year-end, per SEC filings.
$210.2MFY2025 · since FY2016: $5.0M → $210.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $210.2M | -7.7% |
| FY2024 | $227.7M | +39.7% |
| FY2023 | $163.0M | +37.9% |
| FY2022 | $118.2M | +160.6% |
| FY2021 | $45.4M | +120.8% |
| FY2020 | $20.5M | -25.3% |
| FY2019 | $27.5M | +97.1% |
| FY2018 | $14.0M | +100.8% |
| FY2017 | $6.9M | +37.8% |
| FY2016 | $5.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RYTM financial trends
RYTM RevenueRYTM Net incomeRYTM Net marginRYTM Gross profitRYTM Gross marginRYTM Operating incomeRYTM Operating marginRYTM Operating cash flowRYTM Free cash flowRYTM Capital expendituresRYTM Return on equityRYTM Stock buybacksRYTM Dividends paidRYTM Total assetsRYTM Shareholders’ equityRYTM overview →